Vanguard Global Advisers’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.58M Sell
12,053
-248
-2% -$31.7K ﹤0.01% 1413
2026
Q2
$2.33M Sell
12,301
-50
-0.4% -$7.42K ﹤0.01% 1158
2026
Q1
$1.15M Buy
+12,351
New +$1.09M ﹤0.01% 1564

Other funds holding ACLS

Vanguard Global Advisers's ACLS Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Axcelis (ACLS) stake by 2% in Q3 2026, selling an estimated $31.7K and leaving 12,053 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

Vanguard Global Advisers first reported a position in ACLS in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.33M in Q2 2026. 390 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • Vanguard Global Advisers held 12,053 shares of Axcelis worth $1.58M as of Q3 2026.
  • Vanguard Global Advisers sold 248 Axcelis shares in Q3 2026, an estimated $31.7K.
  • Axcelis made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1413 holding.
  • Vanguard Global Advisers first reported a position in Axcelis in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Axcelis position peaked at $2.33M in Q2 2026.
  • 390 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.